Oncolytics Biotech's three largest insider shareholders as of July 26, 2026 are Bernd R. Seizinger (Director, 566.99K shares), Kirk Look (Chief Financial Officer, 287.51K shares), Thomas Charles Heineman (Chief Medical Officer, 282.82K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Patricia S Andrews | - | 78,128 | 0 | 13 Feb, 2026 |
| Bernd R. Seizinger | - | 566,991 | 0 | 13 Feb, 2026 |
| Andrew Aromando | Chief Business Officer | 55,100 | 0 | 13 Feb, 2026 |
| Thomas Charles Heineman | Chief Medical Officer | 282,818 | 0 | 13 Feb, 2026 |
| Deborah Margaret Brown | - | 109,851 | 0 | 13 Feb, 2026 |
| Jared Kelly | Chief Executive Officer | 114,050 | 0 | 13 Mar, 2026 |
| Kirk Look | Chief Financial Officer | 287,515 | 0 | 13 Feb, 2026 |
| Allison Hagerman | Vp, Product Development | 115,059 | 0 | 13 Feb, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 12 Mar, 2026 | Jared Kelly | Common Shares | A | 5,050 | $0.96 | 114,050 | D | P |
| 12 Feb, 2026 | Patricia S Andrews | Common Shares | A | 35,400 | $0.86 | 78,128 | D | P |
| 11 Feb, 2026 | Jared Kelly | Common Shares | A | 5,600 | $0.84 | 79,500 | D | P |
| 12 Feb, 2026 | Thomas Charles Heineman | Common Shares | A | 12,132 | $0.83 | 282,818 | D | P |
| 12 Feb, 2026 | Allison Hagerman | Common Shares | A | 10,000 | $0.83 | 115,059 | D | P |
| 12 Feb, 2026 | Deborah Margaret Brown | Common Shares | A | 25,000 | $0.85 | 109,851 | D | P |
| 12 Feb, 2026 | Kirk Look | Common Shares | A | 12,000 | $0.84 | 287,515 | D | P |
| 11 Feb, 2026 | Andrew Aromando | Common Shares | A | 29,600 | $0.86 | 55,100 | D | P |
| 11 Feb, 2026 | Bernd R. Seizinger | Common Shares | A | 60,000 | $0.83 | 526,991 | D | P |
| 11 Feb, 2026 | Bernd R. Seizinger | Common Shares | A | 60,000 | $0.83 | 526,991 | D | P |
| 11 Feb, 2026 | Bernd R. Seizinger | Common Shares | A | 60,000 | $0.83 | 526,991 | D | P |
| 12 Feb, 2026 | Bernd R. Seizinger | Common Shares | A | 40,000 | $0.85 | 566,991 | D | P |
| 12 Feb, 2026 | Bernd R. Seizinger | Common Shares | A | 40,000 | $0.85 | 566,991 | D | P |
| 12 Feb, 2026 | Jared Kelly | Common Shares | A | 29,500 | $0.84 | 109,000 | D | P |
| 12 Feb, 2026 | Bernd R. Seizinger | Common Shares | A | 40,000 | $0.85 | 566,991 | D | P |
| 16 Jan, 2026 | Bernd R. Seizinger | Common Shares | A | 100,000 | $1.04 | 466,991 | D | P |
| 16 Jan, 2026 | Bernd R. Seizinger | Common Shares | A | 100,000 | $1.04 | 466,991 | D | P |
| 16 Jan, 2026 | Bernd R. Seizinger | Common Shares | A | 100,000 | $1.04 | 466,991 | D | P |